NPI: 1629027578 · EAU CLAIRE, WI 54703 · Pharmacy · NPI assigned 05/09/2006
Authorized official BORTNEM, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | BORTNEM, MARK (CFO) |
| NPI Enumeration Date | 05/09/2006 |
Other providers sharing the same authorized official: BORTNEM, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 137,077 | $1.79M |
| 2019 | 129,264 | $1.62M |
| 2020 | 132,044 | $2.45M |
| 2021 | 203,585 | $3.67M |
| 2022 | 172,412 | $2.55M |
| 2023 | 163,264 | $2.22M |
| 2024 | 160,727 | $2.52M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 42,096 | 36,281 | $2.88M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,742 | 13,302 | $953K |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,327 | 8,078 | $880K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20,256 | 17,329 | $722K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,581 | 12,068 | $625K |
| 80053 | Comprehensive metabolic panel | 26,482 | 22,373 | $587K |
| 87507 | 1,393 | 1,333 | $481K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 24,040 | 20,502 | $414K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 70,524 | 52,356 | $386K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,359 | 4,011 | $367K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10,683 | 9,910 | $339K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10,670 | 9,902 | $334K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 30,911 | 26,142 | $293K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,511 | 4,987 | $266K |
| 70450 | Computed tomography, head or brain; without contrast material | 5,196 | 4,579 | $251K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8,223 | 6,705 | $221K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 47,581 | 38,419 | $219K |
| 84443 | Thyroid stimulating hormone (TSH) | 16,004 | 14,744 | $175K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,818 | 4,370 | $168K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,191 | 2,052 | $168K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,225 | 1,125 | $158K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,605 | 3,058 | $152K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5,887 | 5,525 | $125K |
| 87631 | 1,115 | 1,036 | $121K | |
| 85610 | 14,557 | 8,952 | $115K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 14,798 | 13,533 | $113K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,002 | 3,110 | $111K |
| 64483 | 787 | 729 | $105K | |
| 87480 | 5,645 | 5,166 | $101K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 18,446 | 15,530 | $98K |
| 87660 | 5,645 | 5,166 | $94K | |
| 87510 | 5,647 | 5,167 | $94K | |
| H2012 | Behavioral health day treatment, per hour | 1,724 | 206 | $92K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 224 | 215 | $91K |
| 80061 | Lipid panel | 8,776 | 8,354 | $89K |
| 93308 | 879 | 806 | $85K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,915 | 1,752 | $84K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,876 | 5,235 | $81K |
| 11721 | 1,977 | 1,936 | $81K | |
| 87653 | 2,403 | 2,268 | $79K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 4,550 | 4,378 | $77K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,740 | 5,902 | $75K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 694 | 655 | $74K |
| 71046 | Radiologic examination, chest; 2 views | 6,845 | 6,204 | $73K |
| 87070 | 6,826 | 6,242 | $73K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,381 | 1,228 | $72K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 847 | 741 | $69K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,634 | 1,534 | $69K |
| 83036 | Hemoglobin; glycosylated (A1C) | 10,379 | 9,886 | $69K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,204 | 2,440 | $68K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,891 | 1,533 | $67K |
| 82948 | 7,532 | 3,206 | $67K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,250 | 950 | $66K |
| 87077 | 7,759 | 6,661 | $63K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,186 | 1,250 | $57K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,495 | 3,981 | $56K |
| 82728 | 4,936 | 4,675 | $56K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,837 | 1,774 | $55K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,208 | 1,092 | $52K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 452 | 400 | $52K |
| 93296 | 2,753 | 2,655 | $50K | |
| 84484 | 6,139 | 5,062 | $49K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,110 | 4,035 | $49K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,863 | 1,676 | $48K |
| 86803 | 3,675 | 3,488 | $46K | |
| 84439 | 6,013 | 5,609 | $45K | |
| 80306 | 3,114 | 2,775 | $45K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 452 | 432 | $44K |
| 83605 | 6,835 | 5,877 | $42K | |
| 81025 | 4,418 | 3,964 | $42K | |
| 86780 | 4,555 | 4,248 | $41K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,268 | 2,030 | $41K |
| 80050 | General health panel | 1,007 | 835 | $41K |
| 85027 | 9,410 | 8,405 | $40K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 710 | 400 | $39K |
| 87186 | 5,902 | 5,356 | $38K | |
| 93321 | 624 | 582 | $37K | |
| 95886 | 1,366 | 1,192 | $37K | |
| 84702 | 2,402 | 1,985 | $37K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,638 | 1,556 | $36K |
| G0378 | Hospital observation service, per hour | 5,358 | 2,665 | $35K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 328 | 302 | $35K |
| 81001 | 10,919 | 9,761 | $34K | |
| 86850 | 4,101 | 3,530 | $34K | |
| 87340 | 3,939 | 3,676 | $34K | |
| 82607 | 3,079 | 2,937 | $34K | |
| 86480 | 715 | 663 | $33K | |
| 88142 | 1,607 | 1,543 | $32K | |
| 90834 | Psychotherapy, 45 minutes with patient | 7,807 | 5,613 | $32K |
| 83970 | 1,365 | 1,283 | $32K | |
| 83880 | 2,570 | 2,309 | $31K | |
| 86618 | 2,116 | 1,999 | $31K | |
| 82947 | 6,046 | 4,504 | $31K | |
| 83735 | 7,910 | 6,445 | $28K | |
| 86140 | 7,827 | 6,990 | $28K | |
| 82805 | 1,588 | 1,391 | $28K | |
| 82565 | 5,746 | 5,094 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 711 | 651 | $27K |
| 83690 | 6,834 | 5,984 | $27K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 674 | 632 | $27K |
| 82077 | 3,136 | 2,689 | $26K | |
| Q3014 | Telehealth originating site facility fee | 4,261 | 3,685 | $26K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,272 | 594 | $25K |
| 94060 | 1,030 | 978 | $25K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,659 | 2,329 | $24K |
| 93225 | 866 | 766 | $23K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,043 | 941 | $23K |
| 86762 | 1,848 | 1,680 | $23K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 41 | 39 | $23K |
| V5011 | Fitting/orientation/checking of hearing aid | 113 | 107 | $22K |
| 87103 | 2,400 | 2,113 | $22K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,214 | 1,449 | $21K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 490 | 467 | $20K |
| 87040 | 4,445 | 2,112 | $20K | |
| 71250 | 905 | 849 | $20K | |
| 88342 | 1,320 | 1,187 | $20K | |
| 20610 | 1,391 | 1,234 | $20K | |
| 80143 | 1,957 | 1,719 | $19K | |
| 80179 | 1,930 | 1,696 | $19K | |
| 83550 | 2,977 | 2,831 | $18K | |
| 74018 | 967 | 866 | $18K | |
| 82570 | 4,306 | 3,737 | $17K | |
| 72100 | 1,124 | 1,050 | $16K | |
| 85379 | 2,867 | 2,586 | $16K | |
| 93971 | 863 | 804 | $15K | |
| 93017 | 654 | 610 | $15K | |
| 76830 | Ultrasound, transvaginal | 579 | 532 | $15K |
| 93976 | 525 | 483 | $14K | |
| 81003 | 6,119 | 5,624 | $14K | |
| 93325 | 780 | 727 | $14K | |
| 83540 | 3,012 | 2,864 | $14K | |
| 82043 | 3,168 | 3,026 | $13K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3,290 | 3,161 | $13K |
| 82746 | 1,271 | 1,207 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,432 | 6,772 | $12K |
| 97162 | 2,009 | 1,899 | $12K | |
| 86481 | 202 | 186 | $12K | |
| 99215 | Prolong outpt/office vis | 1,760 | 1,636 | $12K |
| 84153 | 909 | 870 | $12K | |
| 72040 | 362 | 342 | $12K | |
| 87999 | 310 | 258 | $12K | |
| 82248 | 4,496 | 3,967 | $12K | |
| 80076 | 1,559 | 1,463 | $11K | |
| 84450 | 3,497 | 3,100 | $11K | |
| 84460 | 3,048 | 2,702 | $11K | |
| 86376 | 1,012 | 894 | $10K | |
| 83516 | 1,103 | 669 | $10K | |
| 84165 | 981 | 695 | $9K | |
| 82784 | 845 | 739 | $9K | |
| 84146 | 538 | 509 | $9K | |
| J0248 | Injection, remdesivir, 1 mg | 254 | 24 | $9K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 94 | 78 | $8K |
| 86038 | 886 | 829 | $8K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 187 | 176 | $8K |
| 97161 | 577 | 541 | $7K | |
| 80047 | 322 | 285 | $7K | |
| 86787 | 1,130 | 1,021 | $7K | |
| 86706 | 827 | 788 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 382 | 369 | $7K |
| 86900 | 3,525 | 3,019 | $7K | |
| 84132 | 2,157 | 1,800 | $7K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 17 | 15 | $7K |
| 70498 | 91 | 88 | $7K | |
| 86901 | 3,514 | 3,016 | $6K | |
| 20553 | 143 | 138 | $6K | |
| 73502 | 1,459 | 1,352 | $6K | |
| 73630 | 2,824 | 2,281 | $6K | |
| 95812 | 38 | 36 | $6K | |
| 85018 | 3,076 | 2,746 | $6K | |
| 86769 | 362 | 342 | $5K | |
| 94726 | 843 | 805 | $5K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 686 | 655 | $5K |
| 80164 | 513 | 466 | $5K | |
| 82950 | 1,160 | 1,095 | $5K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 646 | 293 | $5K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 62 | 52 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,724 | 1,055 | $5K |
| 70496 | 64 | 63 | $5K | |
| 94729 | 1,018 | 971 | $5K | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 274 | 264 | $5K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 731 | 687 | $5K |
| 88304 | 645 | 580 | $5K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 2,223 | 1,751 | $5K |
| 92134 | 3,946 | 3,790 | $5K | |
| 82803 | 300 | 269 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 922 | 863 | $5K |
| 93226 | 748 | 671 | $5K | |
| 87075 | 1,008 | 855 | $5K | |
| 71045 | Radiologic examination, chest; single view | 6,770 | 5,897 | $4K |
| 86334 | 306 | 223 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 546 | 411 | $4K |
| 80178 | 752 | 658 | $4K | |
| 85652 | 2,311 | 2,146 | $4K | |
| 84100 | 1,564 | 1,324 | $4K | |
| 82550 | 871 | 745 | $4K | |
| 73030 | 1,862 | 1,591 | $4K | |
| 86364 | 237 | 219 | $3K | |
| 64635 | 14 | 14 | $3K | |
| 82105 | 300 | 270 | $3K | |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 765 | 651 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,615 | 9,350 | $3K |
| 90715 | 670 | 630 | $3K | |
| 73130 | 1,117 | 871 | $3K | |
| 88341 | 101 | 95 | $3K | |
| 95910 | 77 | 77 | $3K | |
| 82310 | 694 | 608 | $3K | |
| 73564 | 2,377 | 1,903 | $3K | |
| 82247 | 431 | 349 | $3K | |
| 73110 | 939 | 765 | $3K | |
| 83521 | 159 | 149 | $3K | |
| 0240U | 113 | 100 | $3K | |
| 73610 | 1,502 | 1,291 | $3K | |
| 88307 | 141 | 118 | $3K | |
| 88738 | 129 | 126 | $3K | |
| 90837 | Psychotherapy, 53 minutes with patient | 998 | 669 | $3K |
| 93229 | 164 | 144 | $3K | |
| 76770 | 66 | 66 | $3K | |
| 93923 | 133 | 128 | $3K | |
| 62323 | 13 | 12 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,465 | 6,547 | $3K |
| 64636 | 17 | 13 | $3K | |
| 84156 | 974 | 837 | $3K | |
| 72110 | 118 | 112 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 30,757 | 23,949 | $2K |
| 97165 | 205 | 191 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 60 | 53 | $2K |
| 80069 | 575 | 545 | $2K | |
| 99024 | 859 | 683 | $2K | |
| 70486 | 67 | 61 | $2K | |
| 87478 | 97 | 88 | $2K | |
| 86704 | 206 | 202 | $2K | |
| 84550 | 907 | 823 | $2K | |
| 83001 | 125 | 119 | $2K | |
| 95800 | 41 | 39 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 40 | 36 | $2K |
| 64493 | 14 | 13 | $2K | |
| 77002 | 128 | 115 | $2K | |
| 92557 | 203 | 200 | $2K | |
| 86235 | 28 | 26 | $2K | |
| 83615 | 659 | 590 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | 208 | 147 | $2K |
| 12001 | 24 | 24 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 28 | 25 | $2K |
| 94762 | 27 | 26 | $1K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 16 | 13 | $1K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 654 | 427 | $1K |
| 84155 | 672 | 616 | $1K | |
| 95908 | 31 | 31 | $1K | |
| 82378 | 105 | 75 | $1K | |
| 76882 | 69 | 61 | $1K | |
| 88141 | 76 | 74 | $1K | |
| 74174 | 16 | 13 | $1K | |
| 82533 | 84 | 72 | $1K | |
| 86696 | 56 | 50 | $1K | |
| 86431 | 223 | 215 | $1K | |
| 93280 | 97 | 92 | $948.31 | |
| 64566 | 20 | 12 | $943.67 | |
| 84295 | 262 | 226 | $881.33 | |
| 93351 | 14 | 13 | $858.74 | |
| 95885 | 53 | 40 | $798.32 | |
| 91322 | 179 | 163 | $767.48 | |
| 99205 | Prolong outpt/office vis | 170 | 168 | $755.98 |
| 97116 | 102 | 72 | $747.89 | |
| J0178 | Injection, aflibercept, 1 mg | 739 | 570 | $736.91 |
| 85730 | 267 | 243 | $718.55 | |
| 87529 | 26 | 13 | $705.72 | |
| 86695 | 56 | 50 | $702.14 | |
| 82657 | 25 | 25 | $623.54 | |
| 29581 | 661 | 231 | $617.25 | |
| 51702 | 322 | 288 | $612.74 | |
| 84075 | 196 | 154 | $583.78 | |
| 94618 | 53 | 51 | $559.25 | |
| 90686 | 559 | 535 | $556.59 | |
| 72050 | 26 | 26 | $535.01 | |
| 77091 | 115 | 112 | $504.08 | |
| 76942 | 768 | 707 | $486.55 | |
| 69210 | 73 | 69 | $472.03 | |
| 36591 | 421 | 289 | $467.03 | |
| 93970 | 27 | 25 | $435.06 | |
| 82977 | 25 | 24 | $427.44 | |
| 82010 | 75 | 68 | $424.80 | |
| 96368 | 15 | 13 | $414.29 | |
| 82375 | 72 | 66 | $410.35 | |
| 74178 | 42 | 41 | $407.52 | |
| C9257 | Injection, bevacizumab, 0.25 mg | 94 | 78 | $395.51 |
| 87493 | 15 | 14 | $382.76 | |
| 88108 | 28 | 25 | $379.06 | |
| 97166 | 29 | 28 | $326.18 | |
| 93880 | 14 | 14 | $314.74 | |
| J3490 | Unclassified drugs | 3,813 | 2,848 | $308.00 |
| 51798 | 1,388 | 1,311 | $307.32 | |
| 85014 | 189 | 171 | $246.45 | |
| 90480 | 179 | 163 | $245.12 | |
| 64615 | 92 | 81 | $241.88 | |
| 94010 | 26 | 26 | $231.25 | |
| 87205 | 120 | 95 | $228.81 | |
| 82040 | 79 | 75 | $228.64 | |
| 87206 | 57 | 40 | $202.17 | |
| 20552 | 12 | 12 | $201.15 | |
| 96367 | 24 | 16 | $192.18 | |
| 0097U | 741 | 703 | $179.72 | |
| 98968 | 26 | 20 | $179.63 | |
| 90832 | Psychotherapy, 30 minutes with patient | 42 | 41 | $179.62 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 44 | 43 | $178.76 |
| 96376 | 2,532 | 1,868 | $175.20 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,863 | 2,956 | $159.37 |
| 36416 | 7,738 | 4,450 | $159.17 | |
| G0379 | Direct admission of patient for hospital observation care | 19 | 16 | $152.46 |
| 82140 | 14 | 12 | $136.81 | |
| 99495 | 106 | 105 | $133.82 | |
| 74019 | 40 | 38 | $121.48 | |
| 83050 | 70 | 65 | $120.26 | |
| 84560 | 34 | 28 | $120.24 | |
| 86705 | 12 | 12 | $118.88 | |
| 87102 | 31 | 25 | $117.11 | |
| J2704 | Injection, propofol, 10 mg | 21,946 | 7,858 | $109.38 |
| 84520 | 38 | 37 | $101.93 | |
| 76376 | 586 | 544 | $92.53 | |
| 84145 | 29 | 25 | $91.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 79 | 79 | $89.21 |
| 73080 | 161 | 139 | $77.53 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 609 | 576 | $76.47 |
| 77065 | Tomosynthesis, mammo | 30 | 28 | $71.30 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,137 | 956 | $68.90 |
| 72170 | 76 | 65 | $68.69 | |
| 97035 | 56 | 31 | $52.25 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,607 | 6,198 | $51.16 |
| 90656 | 26 | 24 | $49.22 | |
| 90791 | Psychiatric diagnostic evaluation | 28 | 28 | $38.85 |
| C1769 | Guide wire | 1,470 | 1,295 | $33.95 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 37 | 37 | $33.83 |
| 83718 | 49 | 48 | $32.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,243 | 7,083 | $31.18 |
| J1644 | Injection, heparin sodium, per 1000 units | 1,972 | 1,125 | $30.56 |
| 73590 | 82 | 67 | $30.41 | |
| 90662 | 459 | 437 | $27.93 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 9,259 | 7,915 | $21.95 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 405 | 219 | $21.80 |
| 0764T | 45 | 42 | $21.42 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,177 | 835 | $21.24 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 954 | 893 | $20.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,372 | 8,658 | $20.08 |
| 11102 | 14 | 12 | $18.99 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 2,755 | 1,299 | $16.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,185 | 7,255 | $15.86 |
| 82465 | 36 | 35 | $12.74 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 6,646 | 5,114 | $11.55 |
| J7050 | Infusion, normal saline solution, 250 cc | 809 | 527 | $10.94 |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,341 | 2,576 | $10.86 |
| 99496 | 92 | 88 | $8.24 | |
| 0004A | 38 | 32 | $5.78 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,360 | 2,317 | $5.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,223 | 932 | $3.57 |
| 0124A | 79 | 78 | $2.02 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,957 | 1,535 | $1.20 |
| J2060 | Injection, lorazepam, 2 mg | 990 | 739 | $0.95 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 209 | 174 | $0.91 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 901 | 523 | $0.56 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 770 | 690 | $0.25 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 417 | 369 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 767 | 395 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 276 | 238 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,363 | 3,642 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 34 | 26 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,566 | 4,270 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 625 | 441 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 848 | 696 | $0.00 |
| A9270 | Non-covered item or service | 9,666 | 7,170 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 544 | 503 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 924 | 811 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 133 | 94 | $0.00 |
| 0754T | 41 | 36 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 108 | 85 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 80 | 76 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 97 | 92 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 91 | 67 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 823 | 806 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 100 | 91 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 19 | 18 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 25 | 25 | $0.00 |
| 88300 | 41 | 39 | $0.00 | |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | 21 | 12 | $0.00 |
| 73552 | 15 | 13 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 40 | 27 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 18 | 15 | $0.00 |
| G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | 12 | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 26 | 17 | $0.00 |
| G8991 | Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 14 | 12 | $0.00 |
| 92567 | 12 | 12 | $0.00 | |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 21 | 12 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 69 | 39 | $0.00 |
| 73090 | 17 | 15 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 14 | 12 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 18 | 12 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 47 | 36 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 24 | 12 | $0.00 |
| 0753T | 2,394 | 1,959 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,306 | 2,093 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 334 | 171 | $0.00 |
| 0752T | 286 | 262 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 510 | 391 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 373 | 323 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 343 | 307 | $0.00 |
| 0760T | 241 | 218 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 31 | 25 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 281 | 211 | $0.00 |
| 17110 | 15 | 15 | $0.00 | |
| 77080 | 141 | 138 | $0.00 | |
| 73140 | 23 | 17 | $0.00 | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 39 | 39 | $0.00 |
| 31575 | 12 | 12 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 312 | 281 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 27 | 25 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 58 | 53 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 49 | 37 | $0.00 |
| 0054A | 30 | 30 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 77 | 69 | $0.00 |
| 0761T | 46 | 36 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 19 | 13 | $0.00 |
| C2625 | Stent, non-coronary, temporary, with delivery system | 14 | 12 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,160 | 475 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 28 | 27 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 12 | 12 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 28 | 26 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 16 | 14 | $0.00 |
| 76937 | 14 | 12 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 109 | 66 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 25 | 15 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 17 | 14 | $0.00 |
| 0003A | 16 | 14 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 20 | 12 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 16 | 15 | $0.00 |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 13 | 13 | $0.00 |
| 76642 | 18 | 18 | $0.00 |